Perioperative Intravenous Lidocaine in Liver Surgery
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This is a randomized double blinded placebo-controlled study, conducted in Lund, Sweden.
Patients will be randomized in two groups, with a ratio of 1:1. The experimental arm will
receive intravenous Lidocaine perioperatively, and the Control arm will receive placebo, i.e.
normal Saline. Postoperative both arms will get routine pain Control with PCA, Patient
Controlled Analgesia with an intravenous Oxycodone-infusion. Outcome-measures will include
patients pain intensity scoring, and opioid consumption.